Study: Biotech Sector Ripe for Patent Trolling

, The Recorder

   | 0 Comments

A study from UC-Hastings law professor Robin Feldman anticipates that Big Pharma will be the next target for patent monetizers.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202643208587

Thank you!

This article's comments will be reviewed.